GROUP ONE TRADING, L.P. - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is and the CUSIP is P73398902. A total of 3 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$171
-84.4%
900
-75.7%
0.00%
Q4 2022$1,0993,700
+1750.0%
0.00%
Q3 2022$02000.0%0.00%
Q2 2022$0
-100.0%
200
-98.0%
0.00%
Q1 2022$13,000
+160.0%
10,100
+159.0%
0.00%
Q4 2021$5,000
-50.0%
3,900
-22.0%
0.00%
Q3 2021$10,000
-79.2%
5,000
-62.7%
0.00%
Q2 2020$48,000
+700.0%
13,400
+396.3%
0.00%
Q1 2020$6,000
-53.8%
2,700
-55.0%
0.00%
Q4 2019$13,0000.0%6,000
-13.0%
0.00%
Q3 2019$13,000
+85.7%
6,900
+46.8%
0.00%
Q2 2019$7,000
+250.0%
4,700
+291.7%
0.00%
Q1 2019$2,000
-93.9%
1,200
-95.2%
0.00%
Q4 2018$33,000
-35.3%
24,900
+19.1%
0.00%
Q3 2018$51,000
-27.1%
20,900
+1.0%
0.00%
-100.0%
Q2 2018$70,000
+900.0%
20,700
+1193.8%
0.00%
Q1 2018$7,000
-56.2%
1,600
-66.0%
0.00%
Q4 2017$16,000
+60.0%
4,700
+88.0%
0.00%
Q3 2017$10,000
-95.2%
2,500
-94.7%
0.00%
-100.0%
Q2 2017$209,000
+17.4%
47,500
-2.9%
0.00%0.0%
Q1 2017$178,000
-22.6%
48,900
-43.3%
0.00%0.0%
Q4 2016$230,000
-60.3%
86,300
-51.4%
0.00%
-66.7%
Q3 2016$579,000
+992.5%
177,500
+1023.4%
0.01%
+500.0%
Q2 2016$53,000
-61.6%
15,800
-72.1%
0.00%
-50.0%
Q1 2016$138,000
+79.2%
56,700
+141.3%
0.00%
+100.0%
Q4 2015$77,00023,5000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q2 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 200$00.00%
SIMPLEX TRADING, LLC 3,600$1,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders